Low dose orbital radiotherapy for thyroid eye disease

Orbit

Volumn 30, Issue 6, 2011, Pages 269-274

  Li Yim, James F T ^a   Sandinha, Teresa ^a   Kerr, Jan M ^a   Ritchie, Diana ^b   Kemp, Ewan G ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Exophthalmos; Ophthalmopathy; Orbital radiotherapy; Proptosis; Thyroid eye disease

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; ORBIT; RADIATION DOSE; REVIEW; STEROID THERAPY; THYROID DISEASE; TREATMENT RESPONSE; VISUAL ACUITY;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 82655183591     PISSN: 01676830     EISSN: 17445108     Source Type: Journal    
DOI: 10.3109/01676830.2011.615455     Document Type: Review

References (30)

1. Gorman CA, Garrity JA, Fatourechi V, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves ophthalmopathy. Ophthalmology 2001;108:1523-1534. (Pubitemid 32808323)
2. Gorman CA, Garrity JA, Fatourechi V, et al. The aftermath of orbital radiotherapy for graves ophthalmopathy. Ophthalmology 2002;109:2100-2107. (Pubitemid 35222568)
3. Ferris JD, Dawson EL, Plowman N, et al. Radiotherapy in thyroid eye disease: The effect on the field of binocular single vision. J AAPOS 2002;6:71-76. (Pubitemid 41080268)
4. Ohtsuka K, Sato A, Kawaguchi S, et al. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves ophthalmopathy. Am J Ophthalmol 2003;135:285-290. (Pubitemid 36279512)
5. Bradley EA, Gower EW, Bradley DJ, et al. Orbital radiation for graves ophthalmopathy: A report by the American Academy of Ophthalmology. Ophthalmology 2008;115:398-409.
6. Pinchera A, Wiersinga W, Glinoer D, et al. Classification of eye changes of Graves disease. Thyroid. 1992;2:235-236.
7. Hurbli T, Char DH, Harris J, et al. Radiation therapy for thyroid eye diseases. Am J Ophthalmol 1985;99:633-637. (Pubitemid 15059933)
8. Palmer D, Greenberg P, Cornell P, et al. Radiation therapy for Graves ophthalmopathy: A retrospective analysis. Int J Radiat Oncol Biol Phys 1987;13:1815-1820. (Pubitemid 18011336)
9. Wiersinga WM, Smit T, Schuster-Uittenhoeve AL, et al. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves ophthalmopathy. Ophthalmologica 1988;197:75-84.
10. Kazim M, Trokel S, Moore S. Treatment of acute Graves orbitopathy. Ophthalmology 1991;98:1443-1448.
11. Claridge KG, Ghabrial R, Davis G, et al. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease. Eye (Lond) 1997;11 (Pt 5):717-722. (Pubitemid 27499832)
12. Marquez SD, Lum BL, McDougall IR, et al. Long-term results of irradiation for patients with progressive Graves ophthalmopathy. Int J Radiat Oncol Biol Phys 2001;51:766-774.
13. Mourits MP, van Kempen-Harteveld ML, Garc? MB, et al. Radiotherapy for Graves orbitopathy: Randomised placebocontrolled study. Lancet 2000;355:1505-1509. (Pubitemid 30237357)
14. Prummel MF, Terwee CB, Gerding MN, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves ophthalmopathy. J Clin Endocrinol Metab 2004;89:15-20. (Pubitemid 38183852)
15. Ng CM, Yuen HK, Choi KL, et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves ophthalmopathy: A preliminary study. Hong Kong Med J 2005;11:322-330. (Pubitemid 41499549)
16. Weetman AP, Wiersinga WM. Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey. Clin Endocrinol (Oxf) 1998;49:21-28. (Pubitemid 28338039)
17. Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves ophthalmopathy. J Clin Endocrinol Metab 1973;37:276-285.
18. Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves ophthalmopathy: A novel approach. Br J Ophthalmol 1989;73:639-644. (Pubitemid 19202075)
19. Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 1995;42:45-50.
20. Bartley GB, Fatourechi V, Kadrmas EF, et al. The treatment of Graves ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121:200-206. (Pubitemid 26055165)
21. Bartalena L, Pinchera A, Marcocci C. Management of Graves ophthalmopathy: Reality and perspectives. Endocr Rev 2000;21:168-199. (Pubitemid 32275594)
22. McKeag D, Lane C, Lazarus JH, et al.; . European Group on Graves Orbitopathy (EUGOGO) Clinical features of dysthyroid optic neuropathy: A European Group on Graves Orbitopathy (EUGOGO) survey. Br J Ophthalmol 2007;91:455-458. (Pubitemid 46623676)
23. Terwee CB, Prummel MF, Gerding MN, et al. Measuring disease activity to predict therapeutic outcome in Graves ophthalmopathy. Clin Endocrinol (Oxf) 2005;62: 145-155. (Pubitemid 40203908)
24. Hart RH, Kendall-Taylor P, Crombie A, et al. Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome. J Ocul Pharmacol Ther 2005;21:328-336. (Pubitemid 41192904)
25. Sergott RC, Glaser JS. Graves ophthalmopathy. A clinical and immunologic review. Surv Ophthalmol 1981;26:1-21. (Pubitemid 11052010)
26. Kazim M. Perspective-Part II: Radiotherapy for Graves Orbitopathy: The Columbia University experience. Ophthal Plast Reconstr Surg 2002;18:173-174. (Pubitemid 34547550)
27. Miller ML, Goldberg SH, Bullock JD. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol 1991;112:600-601.
28. Viebahn M, Barricks ME, Osterloh MD. Synergism between diabetic and radiation retinopathy: Case report and review. Br J Ophthalmol 1991;75:629-632.
29. Wakelkamp IM, Tan H, Saeed P, et al. Orbital irradiation for Graves ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology 2004;111:1557-1562. (Pubitemid 39030812)
30. Akmansu M, Dirican B, Bora H, et al. The risk of radiationinduced carcinogenesis after external beam radiotherapy of Graves orbitopathy. Ophthalmic Res 2003;35:150-153. (Pubitemid 36506421)